Illumina

YTD

ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions.

CEO

Jacob Thaysen

CEOJacob Thaysen

Employees

10,370

Employees10,370

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1998

Founded1998

Employees

10,370

Employees10,370

ILMN Key Statistics

Market cap

15.82B

Market cap15.82B

Price-Earnings ratio

12.68

Price-Earnings ratio12.68

Dividend yield

—

Dividend yield—

Average volume

1.64M

Average volume1.64M

High today

$101.93

High today$101.93

Low today

$100.06

Low today$100.06

Open price

$101.44

Open price$101.44

Volume

948.51K

Volume948.51K

52 Week high

$156.66

52 Week high$156.66

52 Week low

$68.70

52 Week low$68.70

ILMN News

TipRanks 1d

Illumina price target lowered to $105 from $106 at Baird

Baird lowered the firm’s price target on Illumina (ILMN) to $105 from $106 and keeps a Neutral rating on the shares. The firm updated its model ahead of its Q3...

Benzinga 4d

JPMorgan, Alibaba, Columbia Banking System And A Health Care Stock On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” on Monday, Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, said JPMorgan Chase & Co. (NYSE:JPM) is sti...

TipRanks 5d

Illumina Faces Competitive Threat from Roche’s SBX Platform: Analyst Issues Sell Rating

Illumina, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Ryskin from Bank of America Securities maintained a Sell...

Analyst ratings

48%

of 23 ratings

Buy

39.1%

Hold

47.8%

Sell

13%

More ILMN News

Simply Wall St 7d

What Illumina's 5-Base Sequencing Launch Means for Shareholders

At the recent American Society of Human Genetics conference in Boston, Illumina unveiled its novel 5-base sequencing solution and announced that GeneDx is pilot...

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.